The largest database of trusted experimental protocols

Macs magnetic microbead kit

Manufactured by Miltenyi Biotec
Sourced in Germany

The MACS® magnetic microbead kit is a tool used for the separation and isolation of specific cell types from complex biological samples. It utilizes magnetic beads coated with antibodies that bind to target cells, allowing their isolation through the application of a magnetic field.

Automatically generated - may contain errors

4 protocols using macs magnetic microbead kit

1

Purification of Regulatory T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pooled single cell suspensions of SPCs and lymph node cells (LNCs), herein referred to as peripheral blood mononuclear cells (PBMCs) were obtained from EAE mice 2 weeks after immunosuppressive therapy with MICCop as described above. Regulatory CD4+CD25+ T lymphocytes (Tregs) were purified by consecutive negative isolation of CD4+ cells and positive selection of CD25+ lymphocytes using a MACS® magnetic microbead kit as specified by the manufacturer (Miltenyi Biotec, Bergisch Gladbach, Germany), usually resulting in a purity above 90 % of the CD4+CD25+ cell population. Importantly, initial flow cytometric examination revealed that nearly all (>95 %) CD4+CD25+ lymphocytes also expressed the transcription factor FoxP3.
+ Open protocol
+ Expand
2

Isolation and Analysis of PB and BM Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PB and BM were isolated and analyzed as previously described 47 (link),56 (link),57 (link). Briefly, PB was collected in FACS buffer
(PBS, 2 % FBS, 2 mM EDTA) supplemented with 0.0004 % heparin solution (STEMCELL
Technologies Inc.). RBCs was removed by incubation at 37 °C for 25 minutes with 1 %
Dextran solution in PBS, and room-temperature RBC lysis solution (STEMCELL Technologies
Inc.). PB cells were stained with conjugated antibodies targeting CD4, CD8, NK1.1, CD19,
CD11b, and Gr-1. BM cells were isolated from tibias, femurs and hip bones crushed with a
pestle and mortar. Lineage depletion (B220, CD4, CD8, CD11b, Gr-1, and -Ter119) or c-kit
enrichment was performed using MACS magnetic microbead kit (Miltenyi Biotec) according to
the manufacturer’s instructions. BM cells were stained with conjugated antibodies
against B220, CD4, CD8, CD11b, Gr-1, Ter119, cKit, Sca1, CD48, CD150 APC, CD45.1, CD45.2,
CD105 PE-Cy7, CD41, CD16/32, and MHC class II. Streptavidin-BV510 was used for
biotin-identification. 1 μg/mL propidium Iodide (Molecular Probes) was used to
distinguish viability. Flow cytometry analysis and assisted sorting was performed using
Beckman Coulier (BC) CyAn ADP, Becton Dickinson (BD) LSR Fortessa X-20, and BD Aria
III.
+ Open protocol
+ Expand
3

Isolation and Characterization of PB and BM Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PB and BM were isolated and analyzed as previously described (61 (link), 71 (link), 72 (link)). Briefly, PB was collected in fluorescence-activated cell sorting (FACS) buffer [phosphate-buffered saline (PBS), 2% fetal bovine serum, and 2 mM EDTA] supplemented with 0.0004% heparin solution (STEMCELL Technologies Inc.). RBCs were removed by incubation in 1% dextran solution in PBS at 37°C for 25 min. The cells in the supernatant were isolated and subjected to room-temperature RBC lysis solution (STEMCELL Technologies Inc.). PB cells were stained with conjugated antibodies targeting CD4, CD8, NK1.1, CD19, CD11b, Gr-1, CD45.1, and CD45.2. BM cells were isolated from tibias, femurs and hip bones that were crushed with a pestle and mortar. Lineage depletion (B220, CD4, CD8, CD11b, Gr-1, and Ter119) or c-kit enrichment was performed using MACS magnetic microbead kits (Miltenyi Biotec) according to the manufacturer’s instructions. BM cells were stained with conjugated antibodies against B220, CD4, CD8, CD11b, Gr-1, Ter119, cKit, Sca1, CD48, CD150, CD45.1, CD45.2, CD105, CD41, CD16/32, and MHC class II. Streptavidin-BV510 was used for biotin identification. Propidium Iodide (1 μg/ml; Molecular Probes) was used to distinguish viability. Flow cytometry analysis and assisted cell sorting were performed using Beckman Coulter CyAn ADP, Becton Dickinson (BD) LSRFortessa X-20, and BD Aria III.
+ Open protocol
+ Expand
4

Isolation and Characterization of PB and BM Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PB and BM were isolated and analyzed as previously described (61 (link), 71 (link), 72 (link)). Briefly, PB was collected in fluorescence-activated cell sorting (FACS) buffer [phosphate-buffered saline (PBS), 2% fetal bovine serum, and 2 mM EDTA] supplemented with 0.0004% heparin solution (STEMCELL Technologies Inc.). RBCs were removed by incubation in 1% dextran solution in PBS at 37°C for 25 min. The cells in the supernatant were isolated and subjected to room-temperature RBC lysis solution (STEMCELL Technologies Inc.). PB cells were stained with conjugated antibodies targeting CD4, CD8, NK1.1, CD19, CD11b, Gr-1, CD45.1, and CD45.2. BM cells were isolated from tibias, femurs and hip bones that were crushed with a pestle and mortar. Lineage depletion (B220, CD4, CD8, CD11b, Gr-1, and Ter119) or c-kit enrichment was performed using MACS magnetic microbead kits (Miltenyi Biotec) according to the manufacturer’s instructions. BM cells were stained with conjugated antibodies against B220, CD4, CD8, CD11b, Gr-1, Ter119, cKit, Sca1, CD48, CD150, CD45.1, CD45.2, CD105, CD41, CD16/32, and MHC class II. Streptavidin-BV510 was used for biotin identification. Propidium Iodide (1 μg/ml; Molecular Probes) was used to distinguish viability. Flow cytometry analysis and assisted cell sorting were performed using Beckman Coulter CyAn ADP, Becton Dickinson (BD) LSRFortessa X-20, and BD Aria III.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!